These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37160959)

  • 1. Ketogenic diet enhances the effects of oxycodone in mice.
    Trinko R; Diaz DM; Foscue E; Thompson SL; Taylor JR; DiLeone RJ
    Sci Rep; 2023 May; 13(1):7507. PubMed ID: 37160959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex-specific role for serotonin 5-HT
    Sierra S; Muchhala KH; Jessup DK; Contreras KM; Shah UH; Stevens DL; Jimenez J; Cuno Lavilla XK; de la Fuente Revenga M; Lippold KM; Shen S; Poklis JL; Qiao LY; Dewey WL; Akbarali HI; Damaj MI; González-Maeso J
    Neuropharmacology; 2022 May; 209():108988. PubMed ID: 35183539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability.
    Cooper ZD; Bedi G; Ramesh D; Balter R; Comer SD; Haney M
    Neuropsychopharmacology; 2018 Sep; 43(10):2046-2055. PubMed ID: 29463913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A limited access oral oxycodone paradigm produces physical dependence and mesocorticolimbic region-dependent increases in DeltaFosB expression without preference.
    Iyer V; Woodward TJ; Pacheco R; Hohmann AG
    Neuropharmacology; 2022 Mar; 205():108925. PubMed ID: 34921830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Buprenorphine/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: reduction of pain, opioid withdrawal symptoms, and abuse liability of oral oxycodone.
    Roux P; Sullivan MA; Cohen J; Fugon L; Jones JD; Vosburg SK; Cooper ZD; Manubay JM; Mogali S; Comer SD
    Pain; 2013 Aug; 154(8):1442-8. PubMed ID: 23707283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The G-protein biased mu-opioid agonist, TRV130, produces reinforcing and antinociceptive effects that are comparable to oxycodone in rats.
    Austin Zamarripa C; Edwards SR; Qureshi HN; Yi JN; Blough BE; Freeman KB
    Drug Alcohol Depend; 2018 Nov; 192():158-162. PubMed ID: 30261403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How Motivations for Using Buprenorphine Products Differ From Using Opioid Analgesics: Evidence from an Observational Study of Internet Discussions Among Recreational Users.
    Butler SF; Oyedele NK; Dailey Govoni T; Green JL
    JMIR Public Health Surveill; 2020 Mar; 6(1):e16038. PubMed ID: 32209533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The highly selective dopamine D
    Jordan CJ; Humburg B; Rice M; Bi GH; You ZB; Shaik AB; Cao J; Bonifazi A; Gadiano A; Rais R; Slusher B; Newman AH; Xi ZX
    Neuropharmacology; 2019 Nov; 158():107597. PubMed ID: 30974107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Within-subject comparison of the psychopharmacological profiles of oral oxycodone and oral morphine in non-drug-abusing volunteers.
    Zacny JP; Lichtor SA
    Psychopharmacology (Berl); 2008 Jan; 196(1):105-16. PubMed ID: 17899018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nociceptin/orphanin FQ receptors modulate the discriminative stimulus effects of oxycodone in C57BL/6 mice.
    Walentiny DM; Wiebelhaus JM; Beardsley PM
    Drug Alcohol Depend; 2018 Jun; 187():335-342. PubMed ID: 29705547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of oxycodone and hydrocodone tolerance by diazepam.
    Gonek M; Akbarali HI; Henderson G; Dewey WL
    Brain Res; 2017 Nov; 1674():84-90. PubMed ID: 28830768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of oxycodone, hydrocodone, and morphine on the responses of D2/D3 dopamine receptors.
    Emery MA; Bates ML; Wellman PJ; Eitan S
    Behav Brain Res; 2015 May; 284():37-41. PubMed ID: 25617530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the orexin system for prescription opioid use disorder: Orexin-1 receptor blockade prevents oxycodone taking and seeking in rats.
    Matzeu A; Martin-Fardon R
    Neuropharmacology; 2020 Mar; 164():107906. PubMed ID: 31841797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining a Candidate Vaccine for Opioid Use Disorders with Extended-Release Naltrexone Increases Protection against Oxycodone-Induced Behavioral Effects and Toxicity.
    Raleigh MD; Accetturo C; Pravetoni M
    J Pharmacol Exp Ther; 2020 Sep; 374(3):392-403. PubMed ID: 32586850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the NK1 antagonist, aprepitant, on response to oral and intranasal oxycodone in prescription opioid abusers.
    Walsh SL; Heilig M; Nuzzo PA; Henderson P; Lofwall MR
    Addict Biol; 2013 Mar; 18(2):332-43. PubMed ID: 22260216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of nalfurafine on the reinforcing, thermal antinociceptive, and respiratory-depressant effects of oxycodone: modeling an abuse-deterrent opioid analgesic in rats.
    Townsend EA; Naylor JE; Negus SS; Edwards SR; Qureshi HN; McLendon HW; McCurdy CR; Kapanda CN; do Carmo JM; da Silva FS; Hall JE; Sufka KJ; Freeman KB
    Psychopharmacology (Berl); 2017 Sep; 234(17):2597-2605. PubMed ID: 28567699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single cell transcriptomics reveals distinct transcriptional responses to oxycodone and buprenorphine by iPSC-derived brain organoids from patients with opioid use disorder.
    Ho MF; Zhang C; Moon I; Zhu X; Coombes BJ; Biernacka J; Skime M; Oesterle TS; Karpyak VM; Schmidt K; Gliske K; Ngo Q; Skillon C; Seppala MD; Li H; Weinshilboum RM
    Mol Psychiatry; 2024 Jun; 29(6):1636-1646. PubMed ID: 36302966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of delta-opioid receptor contributes to the antinociceptive effect of oxycodone in mice.
    Yang PP; Yeh GC; Yeh TK; Xi J; Loh HH; Law PY; Tao PL
    Pharmacol Res; 2016 Sep; 111():867-876. PubMed ID: 27496654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the antinociceptive effect of oxycodone in male and female rats.
    Holtman JR; Wala EP
    Pharmacol Biochem Behav; 2006 Jan; 83(1):100-8. PubMed ID: 16434089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of prenatal and early post-natal oxycodone exposure on the reinforcing and antinociceptive effects of oxycodone in adult C57BL/6 J mice.
    Zhang Y; Butelman ER; Kreek MJ
    Psychopharmacology (Berl); 2024 Feb; 241(2):359-377. PubMed ID: 38086926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.